FROM Jon Henke
Sotomayor Hearings; Healthcare; Goldman Sachs Is Sotomayor a shoe-in? The battle for healthcare reform turns critical. Plus, Goldman Sachs and JP Morgan earn millions. Is that good for the country? (With Arianna Huffington and Tony Blankley away, we welcome two new guest hosts, John Henke and Mike Murphy.)
Republicans Regroup as the Opposition Republicans are pointing fingers at one another, but most agree on one thing: even if John McCain had not lost to Barack Obama , the GOP was in trouble. They were saddled with George Bush and the war in Iraq. They failed to control healthcare costs or monitor the economy. Now the party of Ronald Reagan has no consensus on leadership or a set or principles to hold its factions together. We ask a cross-section of Republican operatives and philosophers, what should happen next?
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.